ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.

Jae H Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.